- Home
- KYMR vs ATHM Comparison
KYMR vs ATHM Comparison
Compare KYMR & ATHM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KYMR
- ATHM
- Stock Information
- Founded
- KYMR 2015
- ATHM 2008
- Country
- KYMR United States
- ATHM China
- Employees
- KYMR N/A
- ATHM N/A
- Industry
- KYMR Medicinal Chemicals and Botanical Products
- ATHM EDP Services
- Sector
- KYMR Health Care
- ATHM Technology
- Exchange
- KYMR Nasdaq
- ATHM Nasdaq
- Market Cap
- KYMR 3.1B
- ATHM 2.9B
- IPO Year
- KYMR 2020
- ATHM 2013
- Fundamental
- Price
- KYMR $44.64
- ATHM $26.88
- Analyst Decision
- KYMR Strong Buy
- ATHM Hold
- Analyst Count
- KYMR 16
- ATHM 3
- Target Price
- KYMR $58.94
- ATHM $32.00
- AVG Volume (30 Days)
- KYMR 865.2K
- ATHM 257.4K
- Earning Date
- KYMR 08-06-2025
- ATHM 07-30-2025
- Dividend Yield
- KYMR N/A
- ATHM 6.38%
- EPS Growth
- KYMR N/A
- ATHM N/A
- EPS
- KYMR N/A
- ATHM 1.80
- Revenue
- KYMR $58,885,000.00
- ATHM $948,713,568.00
- Revenue This Year
- KYMR $58.26
- ATHM N/A
- Revenue Next Year
- KYMR N/A
- ATHM $2.08
- P/E Ratio
- KYMR N/A
- ATHM $14.93
- Revenue Growth
- KYMR N/A
- ATHM N/A
- 52 Week Low
- KYMR $19.45
- ATHM $21.89
- 52 Week High
- KYMR $53.27
- ATHM $34.70
- Technical
- Relative Strength Index (RSI)
- KYMR 55.84
- ATHM 59.58
- Support Level
- KYMR $43.56
- ATHM $26.29
- Resistance Level
- KYMR $46.34
- ATHM $27.09
- Average True Range (ATR)
- KYMR 1.81
- ATHM 0.57
- MACD
- KYMR -0.60
- ATHM 0.11
- Stochastic Oscillator
- KYMR 36.21
- ATHM 69.17
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.
About ATHM Autohome Inc.
Founded in 2008 as a media content platform, Autohome is the leading online automobile platform in China, ranking first among automotive service platforms in terms of mobile daily active users, according to QuestMobile. Through its two websites, autohome.com.cn and che168.com, Autohome delivers comprehensive, independent and interactive content and tools to automobile consumers as well as a full suite of services to automakers and dealers. According to iResearch, the company was the largest online automotive advertising and lead generation service provider with 30% market share, in terms of media services and lead generation revenue, in China's online auto platform media advertising market.